Literature DB >> 6673809

Localization of measles virus nucleic acid sequences in infected cells by in situ hybridization.

J G Fournier, S Rozenblatt, M Bouteille.   

Abstract

Vero cells were infected with measles virus and hybridized in situ to a cloned DNA fragment containing specific sequences for measles nucleocapsid protein. The DNA was labelled with tritium by nick-translation. The viral RNA were detected in the cytoplasm 21 hrs after infection. In many cells, the probe hybridized to nuclear structures, and in several mitotic cells, to chromosomes. After 36 hrs of infection, hybridization sites were found both in the center and in many nuclei of all the polykaryons. These results indicate that cellular distribution of viral RNA molecules varies in the course of infection. They further suggest that the nucleus plays a more active role than expected in measles virus transcription and replication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6673809     DOI: 10.1111/j.1768-322x.1984.tb00248.x

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  3 in total

1.  Measles virus matrix protein gene expression in a subacute sclerosing panencephalitis patient brain and virus isolate demonstrated by cDNA hybridization and immunocytochemistry.

Authors:  H R Brown; N L Goller; H Thormar; R Rudelli; W W Tourtellotte; P Shapshak; R Boostanfar; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Do measles early giant cells result from fusion of non-infected cells? An immunohistochemical and in situ hybridization study in a case of morbillous appendicitis.

Authors:  A Gaulier; P Sabatier; S Prevot; J G Fournier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Detection of vesicular stomatitis virus (VSV) RNA in the central nervous system of infected mice by in situ hybridization.

Authors:  J G Fournier; O Robain; I Cerutti; I Tardivel; F Chany-Fournier; C Chany
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.